CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance

Prevalence and incidence of IgE-mediated allergic diseases have increased over the past years in developed and developing countries. Allergen-specific immunotherapy (AIT) is currently the only curative treatment available for allergic diseases that has long-term efficacy. Although AIT has been prove...

Descripció completa

Dades bibliogràfiques

Autors principals:	Guillem Montamat, Cathy Leonard, Aurélie Poli, Ludger Klimek, Markus Ollert
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-02-01
Col·lecció:	Frontiers in Immunology
Matèries:	allergen-specific immunotherapy CpG-oligonucleotides allergy tolerance induction immune tolerance
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.590054/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!